text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "vascular smooth muscle%3A%3A%3A%3Arelevance%3A%3A%3A%3AvisibleToGroups%3A%3A%3A%3Abs_noExclusion%3A%3A%3A%3AvisibleBsCountries%3A%3A%3A%3AUS%3A%3A%3A%3Alon_cl_ProductType%3A%3A%3A%3APrimary Cells"

807 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "vascular smooth muscle%3A%3A%3A%3Arelevance%3A%3A%3A%3AvisibleToGroups%3A%3A%3A%3Abs_noExclusion%3A%3A%3A%3AvisibleBsCountries%3A%3A%3A%3AUS%3A%3A%3A%3Alon_cl_ProductType%3A%3A%3A%3APrimary Cells"

1,082 Documents found
  • TechSheet - Aortic Endothelial Cell Systems
    Technical information sheet for Clonetics™ Aortic Endothelial Cells
  • TechSheet - Pulmonary Artery Endothelial Cell Systems
    Technical information sheet for Clonetics™ Pulmonary Artery Endothelial Cells
  • TechSheet - Coronary Artery Endothelial Cell Systems
    Technical information sheet for Clonetics™ Coronary Artery Endothelial Cells
  • TechSheet - Iliac Artery Endothelial Cell System, HIAEC
    Technical information sheet for Clonetics™ Iliac Artery Endothelial Cells
  • Basic Transfection Protocol for SMC - Nucleofector™ 1/2 Device Series
    Instructions of use for transfection of primary mammalian smooth muscle cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Human AoSMC (Lonza) - Nucleofector™ 1/2 Device Series
    Instructions of use for transfection of human aortic smooth muscle cells (Lonza) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • A7r5 Transfection Protocol - Nucleofector™ 1/2 Device Series
    Instructions of use for transfection of A7r5 cells with the Cell Line Nucleofector™ Kit V
  • Comparison of Normal and Asthmatic Bronchial Epithelial Cells and Smooth Muscle Cells in Monolayer and RAFT™ 3D Cell Culture System
    Understanding the differences between normal and diseased lung cells in 2D vs 3D culture.
  • Electroporation eBook with RegMedNet
    CD-MI286_Electroporation-eBook-RegMedNet_sec.pdf
  • Webinar – Primary and Stem Cell Applications for Diabetes and Obesity Research (pdf)
    Webinar - PDF Version
  • Bioscience Solutions Catalog 2018
    Catalog-Chapter2-Primary-Cells-2018.pdf
  • Brochure - Cell List
    Integrated solutions for primary cells and transfection
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Inventory - Non-Parenchymal Cells
    Listing of available non-parenchymal cells inventory; updated monthly Jun 7 2018 NPC Inventory
  • Lonza Extends Industry-Standard HUVEC Product Line
    Lonza, the market leader in primary cells, has expanded its human primary cell portfolio with an improved version of Human Umbilical Vein Endothelial Cells (HUVEC) cultured in the absence of additive vascular endothelial growth factor (VEGF).
  • Viable Cells - Proliferating Clonetics™ Cells Chart
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • Primary Cells for Airway Research – Infographic
    Infographic showing how Lonza primary cells can aide in your airway research
  • Instructions & Technical Info - Endothelial Cell Systems
    Technical Information and Instructions for Proper Use of Endothelial Cells
  • Assessment of the Anti-Angiogenic Effect of VEGFR2 siRNA in HUVEC Using the Nucleofector™ Technology
    In the White Paper we show the use of our Nucleofector® Technology to transfect single-donor Clonetics® HUVEC with siRNA directed against Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). .
  • 2
  • 3(current)
  • 4